Pipeline
Introducing SK Bioscience's global competitive
vaccine pipeline.
Premium
Basic Vaccine
Coronavirus/Pandemic Response
| Basic Research / Pre-clinical trial |
Clinical Trial Phase I |
Clinical Trial Phase II |
Clinical Trial Phase III |
Government approval |
|
|---|---|---|---|---|---|
21-valent Pneumococcal Protein Conjugate Vaccine  |
 Global |
||||
Next-generation Pneumococcal Vaccine-Adult |
|
||||
Next-generation Pneumococcal Vaccine-Pediatric |
|
||||
9+ valent HPV Vaccine  |
|
||||
Enhanced Influenza Vaccine |
|
||||
13-valent Pneumococcal Protein Conjugate Vaccine |
|
||||
Quadrivalent Cell-cultured Influenza Vaccine(SKYCellflu Quadrivalent) |
* |
||||
Trivalent Cell-cultured Influenza Vaccine(SKYCellflu Trivalent) |
* |
||||
Zoster Vaccine (SKYZoster) |
|
||||
Varicella Vaccine (SKYVaricella) |
* |
||||
Typhoid Protein Conjugate Vaccine(SKYTyphoid [export])  1) 2) |
* |
||||
Varicella Vaccine 2dose (SKYVaricella) |
|
||||
RSV Preventive Monoclonal Antibody |
|
||||
Injectable Rotavirus Vaccine |
|
||||
COVID-19 Vaccine (SKYCovione)  |
|
||||
Pan-sarbecovirus Vaccine  3) |
|
|
|||
Lassa fever Vaccine |
|
||||
Avian Influenza Vaccine |
|
- 1) International Vaccine Institute
- 2) Bill & Melinda Gates Foundation
- 3) Institute for Protein Design